{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:16:32Z","timestamp":1793654192036,"version":"4.5.1"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.virol.2024.110197","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:25:56Z","timestamp":1722428756000},"page":"110197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Evolution and diversity of the hepatitis B virus genome: Clinical implications"],"prefix":"10.1016","volume":"598","author":[{"given":"Chengzuo","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1085-8134","authenticated-orcid":false,"given":"Daiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.virol.2024.110197_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10111440","article-title":"Sustained antiviral and liver protection by a nasal therapeutic vaccine (NASVAC, Containing Both HBsAg and HBcAg) in patients with chronic hepatitis B: 2-year follow-up of phase III clinical trial","volume":"10","author":"Akbar","year":"2021","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.virol.2024.110197_bib2","article-title":"Treatment of chronic hepatitis B naive patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)","volume":"13","author":"Al","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","article-title":"Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase","volume":"125","author":"Angus","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000047","article-title":"Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing","volume":"7","author":"Arasawa","year":"2023","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.virol.2024.110197_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101333","article-title":"Variable proportions of phylogenetic clustering and low levels of antiviral drug resistance among the major HBV sub-genotypes in the Middle East and North Africa","volume":"10","author":"Athamneh","year":"2021","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007206","article-title":"Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC","volume":"14","author":"Bai","year":"2018","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2007.12.024","article-title":"Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response","volume":"48","author":"Baldick","year":"2008","journal-title":"J. Hepatol."},{"issue":"8243","key":"10.1016\/j.virol.2024.110197_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(81)90832-1","article-title":"Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.virol.2024.110197_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01663-19","article-title":"Discovery and selection of hepatitis B virus-derived T cell epitopes for global immunotherapy based on viral indispensability, conservation, and HLA-binding strength","volume":"94","author":"de Beijer","year":"2020","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.virol.2024.110197_bib10","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1128\/JVI.00243-16","article-title":"Single-molecule sequencing reveals complex genome variation of hepatitis B virus during 15 Years of chronic infection following liver transplantation","volume":"90","author":"Betz-Stablein","year":"2016","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","article-title":"Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues","volume":"51","author":"van Bommel","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3851\/IMP2307","article-title":"Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy","volume":"17","author":"van Bommel","year":"2012","journal-title":"Antivir. Ther."},{"issue":"6620","key":"10.1016\/j.virol.2024.110197_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/386088a0","article-title":"Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy","volume":"386","author":"Bottcher","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.510240107","article-title":"High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection","volume":"24","author":"Bozkaya","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.88.3.1059","article-title":"The role of envelope proteins in hepatitis B virus assembly","volume":"88","author":"Bruss","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib16","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1128\/jvi.70.9.5845-5851.1996","article-title":"Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication","volume":"70","author":"Buckwold","year":"1996","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib17","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1053\/j.gastro.2009.08.061","article-title":"Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa","volume":"137","author":"Buster","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00922-20","article-title":"Characterization of the termini of cytoplasmic hepatitis B virus deproteinated relaxed circular DNA","volume":"95","author":"Cai","year":"2020","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1349-7006.2008.00815.x","article-title":"Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells","volume":"99","author":"Cao","year":"2008","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.2020004907","article-title":"Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy","volume":"136","author":"Cao","year":"2020","journal-title":"Blood"},{"issue":"8711","key":"10.1016\/j.virol.2024.110197_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","article-title":"Vaccine-induced escape mutant of hepatitis B virus","volume":"336","author":"Carman","year":"1990","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.virol.2024.110197_bib22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/apt.15753","article-title":"Do the circulating Pre-S\/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?","volume":"51","author":"Cavallone","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jhep.2010.01.006","article-title":"Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance","volume":"52","author":"Chen","year":"2010","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1440-1746.2010.06429.x","article-title":"Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients","volume":"26","author":"Chen","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jinf.2017.05.012","article-title":"Clinical course and perinatal transmission of chronic hepatitis B during pregnancy: a real-world prospective cohort study","volume":"75","author":"Chen","year":"2017","journal-title":"J. Infect."},{"key":"10.1016\/j.virol.2024.110197_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104852","article-title":"Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: analysis of a large cohort of Chinese patients","volume":"180","author":"Chen","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110197_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.105184","article-title":"Analysis of entire hepatitis B virus genomes reveals reversion of mutations to wild type in natural infection, a 15 year follow-up study","volume":"97","author":"Chen","year":"2022","journal-title":"Infect. Genet. Evol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s11262-019-01689-5","article-title":"Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B","volume":"55","author":"Chuaypen","year":"2019","journal-title":"Virus Gene."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12879-018-3161-2","article-title":"Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe","volume":"18","author":"Colagrossi","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"7649","key":"10.1016\/j.virol.2024.110197_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(70)90926-8","article-title":"Virus-like particles in serum of patients with Australia-antigen-associated hepatitis","volume":"1","author":"Dane","year":"1970","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib31","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00705-019-04227-8","article-title":"Complete genome sequence of a divergent strain of Tibetan frog hepatitis B virus associated with a concave-eared torrent frog (Odorrana tormota)","volume":"164","author":"Debat","year":"2019","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(23)00315-1","article-title":"Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection","volume":"9","author":"Delphin","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/JVI.05308-11","article-title":"Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease","volume":"86","author":"Desmond","year":"2012","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2024.110197_bib34","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.1128\/JVI.00832-16","article-title":"Distinct viral lineages from fish and Amphibians reveal the complex evolutionary history of hepadnaviruses","volume":"90","author":"Dill","year":"2016","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajog.2015.09.100","article-title":"#38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission","volume":"214","author":"Dionne-Odom","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"Domingo","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molcel.2006.04.025","article-title":"Native hepatitis B virions and capsids visualized by electron cryomicroscopy","volume":"22","author":"Dryden","year":"2006","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib38","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s41467-023-36772-x","article-title":"Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes","volume":"14","author":"Dufour","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"issue":"1337","key":"10.1016\/j.virol.2024.110197_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc. Biol. Sci."},{"issue":"1337","key":"10.1016\/j.virol.2024.110197_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc. Biol. Sci."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib43","article-title":"Vertical transmission of hepatitis B virus-an update","volume":"11","author":"di Filippo","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib44","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1080\/22221751.2022.2125344","article-title":"Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma","volume":"11","author":"Fu","year":"2022","journal-title":"Emerg. Microb. Infect."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2525","article-title":"Biomarkers of transfusion transmitted occult hepatitis B virus infection: where are we and what next?","volume":"34","author":"Fu","year":"2024","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2893.2002.00304.x","article-title":"World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants","volume":"9","author":"Funk","year":"2002","journal-title":"J. Viral Hepat."},{"issue":"5733","key":"10.1016\/j.virol.2024.110197_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/281646a0","article-title":"Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli","volume":"281","author":"Galibert","year":"1979","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib48","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: a pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2024.110197_bib49","unstructured":"Geneva Organization WH. GLOBAL HEALTH SECTOR STRATEGY ON VIRAL HEPATITIS 2016\u20132021."},{"key":"10.1016\/j.virol.2024.110197_bib50","series-title":"World Health Statistics","year":"2023"},{"issue":"10","key":"10.1016\/j.virol.2024.110197_bib51","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.virol.2024.110197_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11112622","article-title":"Phylogenetic analysis and emerging drug resistance against different nucleoside analogues in hepatitis B virus positive patients","volume":"11","author":"Gohar","year":"2023","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib53","article-title":"Cas9-targeted nanopore sequencing reveals epigenetic heterogeneity after de novo assembly of native full-length hepatitis B virus genomes","volume":"7","author":"Goldsmith","year":"2021","journal-title":"Microb. Genom."},{"issue":"10","key":"10.1016\/j.virol.2024.110197_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1701484","article-title":"The landscape of transcription errors in eukaryotic cells","volume":"3","author":"Gout","year":"2017","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib55","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2008.06.026","article-title":"Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China","volume":"49","author":"Guo","year":"2008","journal-title":"J. Hepatol."},{"issue":"23","key":"10.1016\/j.virol.2024.110197_bib56","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1128\/JVI.01278-15","article-title":"Characterization of a novel hepadnavirus in the white sucker (Catostomus commersonii) from the great lakes region of the United States","volume":"89","author":"Hahn","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib57","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/jmv.21681","article-title":"Clinical and virological effects of long-term (over 5 years) lamivudine therapy","volume":"82","author":"Hashimoto","year":"2010","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","article-title":"Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B","volume":"140","author":"Heathcote","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib59","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/jvi.52.2.396-402.1984","article-title":"Large surface proteins of hepatitis B virus containing the pre-s sequence","volume":"52","author":"Heermann","year":"1984","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2024.110197_bib60","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/carcin\/bgh207","article-title":"Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage","volume":"25","author":"Hsieh","year":"2004","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib61","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2012.05.009","article-title":"Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors","volume":"57","author":"Huang","year":"2012","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib62","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jmv.25430","article-title":"Hepatitis B virus surface gene mutants in immunoprophylaxis-failed infants from Southern China","volume":"91","author":"Huang","year":"2019","journal-title":"J. Med. Virol."},{"issue":"45","key":"10.1016\/j.virol.2024.110197_bib63","doi-asserted-by":"crossref","first-page":"46384","DOI":"10.1074\/jbc.M403568200","article-title":"Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase","volume":"279","author":"Hung","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.virol.2024.110197_bib64","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1093\/nar\/gkt698","article-title":"Direct assessment of transcription fidelity by high-resolution RNA sequencing","volume":"41","author":"Imashimizu","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36093-w","article-title":"Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection","volume":"8","author":"Inuzuka","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.virol.2024.110197_bib66","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/gutjnl-2022-328041","article-title":"Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection","volume":"72","author":"Janssen","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/HEP.0000000000000524","article-title":"Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-alpha in patients with chronic hepatitis B","volume":"79","author":"Jiang","year":"2024","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib68","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/hep.25852","article-title":"Tracing hepatitis B virus to the 16th century in a Korean mummy","volume":"56","author":"Kahila","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02357-23","article-title":"Targeted mutations in IFNalpha2 improve its antiviral activity against various viruses","volume":"14","author":"Karakoese","year":"2023","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-3565(03)00312-4","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States","volume":"2","author":"Keeffe","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"21","key":"10.1016\/j.virol.2024.110197_bib71","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.27771","article-title":"Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure","volume":"62","author":"Kefalakes","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1478-3231.2011.02647.x","article-title":"The influence of YMDD mutation patterns on clinical outcomes in patients with adefovir add-on lamivudine combination treatment","volume":"32","author":"Kim","year":"2012","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054486","article-title":"Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3350\/cmh.2014.20.3.251","article-title":"Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers","volume":"20","author":"Kim","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jviromet.2007.02.015","article-title":"High throughput functional analysis of HIV-1 env genes without cloning","volume":"143","author":"Kirchherr","year":"2007","journal-title":"J. Virol. Methods"},{"issue":"6564","key":"10.1016\/j.virol.2024.110197_bib77","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.abi5658","article-title":"Ten millennia of hepatitis B virus evolution","volume":"374","author":"Kocher","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110197_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1200748","article-title":"Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed\/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center","volume":"14","author":"Kong","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.21049","article-title":"Relationship of serological subtype, basic core promoter and precore mutations to genotypes\/subgenotypes of hepatitis B virus","volume":"80","author":"Kramvis","year":"2008","journal-title":"J. Med. Virol."},{"issue":"25","key":"10.1016\/j.virol.2024.110197_bib80","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jmv.21938","article-title":"Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients","volume":"83","author":"Lee","year":"2011","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/v12050565","article-title":"Hepatitis B virus-X downregulates expression of selenium binding protein 1","volume":"12","author":"Lee","year":"2020","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.virol.2024.110197_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002880","article-title":"Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing","volume":"8","author":"Li","year":"2012","journal-title":"PLoS Pathog."},{"issue":"49","key":"10.1016\/j.virol.2024.110197_bib84","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1016\/j.vaccine.2012.09.031","article-title":"The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.02156-15","article-title":"Single-genome sequencing of hepatitis C virus in donor-recipient pairs distinguishes modes and models of virus transmission and early diversification","volume":"90","author":"Li","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110197_bib86","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26738","article-title":"A potent human neutralizing antibody Fc-dependently reduces established HBV infections","volume":"6","author":"Li","year":"2017","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib87","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12985-021-01707-9","article-title":"The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study","volume":"18","author":"Li","year":"2021","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib88","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.virs.2024.03.003","article-title":"Precore mutation enhances viral replication to facilitate persistent infection especially in HBeAg-negative patients","volume":"39","author":"Li","year":"2024","journal-title":"Virol. Sin."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib89","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","article-title":"Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122","volume":"64","author":"Liang","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib90","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S0618-8278(19)30090-8","article-title":"PS-078-A phase 1b evaluation of HepTcell HBV-specific immunotherapy in nuc-controlled, eAg negative chronic HBV infection","volume":"70","author":"Lim","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib91","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021436","article-title":"Hepatitis B virus genotypes and variants","volume":"5","author":"Lin","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"25","key":"10.1016\/j.virol.2024.110197_bib92","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.7150\/thno.37717","article-title":"HBX-induced miR-5188 impairs FOXO1 to stimulate beta-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma","volume":"9","author":"Lin","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-020-0111-4","article-title":"Silencing MYH9 blocks HBx-induced GSK3beta ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma","volume":"5","author":"Lin","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib94","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1080\/21505594.2021.1999130","article-title":"Hepatitis B virus middle surface antigen loss promotes clinical variant persistence in mouse models","volume":"12","author":"Lin","year":"2021","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089015","article-title":"rtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virus","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib96","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/22221751.2019.1584018","article-title":"Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice","volume":"8","author":"Liu","year":"2019","journal-title":"Emerg. Microb. Infect."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12985-020-01350-w","article-title":"Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies","volume":"17","author":"Liu","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2024.110197_bib98","article-title":"Inflammation pharmacological reaction and YMDD mutational patterns in lamivudine therapeutics hepatitis B virus","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.virol.2024.110197_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105058","article-title":"Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside\/nucleotide analogs","volume":"189","author":"Liu","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110197_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105348","article-title":"Characterization of the tenofovir resistance-associated mutations in the hepatitis B virus isolates across genotypes A to D","volume":"203","author":"Liu","year":"2022","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12985-024-02344-8","article-title":"Peg-IFNalpha combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function","volume":"21","author":"Liu","year":"2024","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib103","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0016-5085(87)90613-5","article-title":"Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection","volume":"92","author":"Lok","year":"1987","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib104","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jhep.2016.05.016","article-title":"Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B","volume":"65","author":"Lok","year":"2016","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.virol.2024.110197_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006784","article-title":"The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation","volume":"13","author":"Long","year":"2017","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib106","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/22221751.2021.1899055","article-title":"Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus","volume":"10","author":"Lu","year":"2021","journal-title":"Emerg. Microb. Infect."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03423-19","article-title":"Involvement of host ATR-CHK1 pathway in hepatitis B virus covalently closed circular DNA formation","volume":"11","author":"Luo","year":"2020","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib108","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12250-020-00194-6","article-title":"Conservative evolution of hepatitis B virus precore and core gene during immune tolerant phase in intrafamilial transmission","volume":"35","author":"Luo","year":"2020","journal-title":"Virol. Sin."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib109","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021410","article-title":"Hepatitis B virus epidemiology","volume":"5","author":"MacLachlan","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1099\/jgv.0.001415","article-title":"ICTV virus taxonomy profile: Hepadnaviridae","volume":"101","author":"Magnius","year":"2020","journal-title":"J. Gen. Virol."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046345","article-title":"Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa","volume":"7","author":"Makondo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110197_bib112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2018.12.003","article-title":"C-terminal truncated HBx protein activates caveolin-1\/LRP6\/beta-catenin\/FRMD5 axis in promoting hepatocarcinogenesis","volume":"444","author":"Mao","year":"2019","journal-title":"Cancer Lett."},{"issue":"9865","key":"10.1016\/j.virol.2024.110197_bib113","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.virol.2024.110197_bib114","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/liv.14155","article-title":"Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection","volume":"39","author":"Marcellin","year":"2019","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib115","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/597808","article-title":"Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients","volume":"199","author":"Margeridon-Thermet","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib116","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/AAC.01601-12","article-title":"Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatment","volume":"57","author":"Margeridon-Thermet","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"RR-2","key":"10.1016\/j.virol.2024.110197_bib117","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib118","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","article-title":"Mechanisms and prevention of vertical transmission in chronic viral hepatitis","volume":"5","author":"Mavilia","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib119","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110197_bib120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.meegid.2017.01.020","article-title":"15year fulminant hepatitis B follow-up in Belgium: viral evolution and signature of demographic change","volume":"49","author":"Mina","year":"2017","journal-title":"Infect. Genet. Evol."},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2024.110197_bib121","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/PL00000061","article-title":"Constrained evolution with respect to gene overlap of hepatitis B virus","volume":"44","author":"Mizokami","year":"1997","journal-title":"J. Mol. Evol."},{"issue":"7705","key":"10.1016\/j.virol.2024.110197_bib122","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-018-0097-z","article-title":"Ancient hepatitis B viruses from the Bronze age to the medieval period","volume":"557","author":"Muhlemann","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.virol.2024.110197_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1204907","article-title":"beta-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy","volume":"14","author":"Nakagawa","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib124","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2893.1997.00066.x","article-title":"Hepatitis B virus genomic heterogeneity: variation between quasispecies may confound molecular epidemiological analyses of transmission incidents","volume":"4","author":"Ngui","year":"1997","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virol.2024.110197_bib125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jgar.2023.02.013","article-title":"Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in Vietnam","volume":"33","author":"Nguyen","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib126","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12072-016-9716-7","article-title":"Association between hepatitis B virus basal core promoter\/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis","volume":"10","author":"Nian","year":"2016","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib127","first-page":"231","article-title":"Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission","volume":"57","author":"Okamoto","year":"1987","journal-title":"Jpn. J. Exp. Med."},{"issue":"21","key":"10.1016\/j.virol.2024.110197_bib128","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1128\/JVI.00996-06","article-title":"Molecular evolution of hepatitis B virus over 25 years","volume":"80","author":"Osiowy","year":"2006","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2024.110197_bib129","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/gut.2010.221846","volume":"60","author":"Papatheodoridis","year":"2011","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12072-017-9825-y","article-title":"Viral factors for HBV mother-to-child transmission","volume":"11","author":"Park","year":"2017","journal-title":"Hepatol Int"},{"issue":"14","key":"10.1016\/j.virol.2024.110197_bib131","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1046\/j.1432-1033.2003.03650.x","article-title":"Fidelity of hepatitis B virus polymerase","volume":"270","author":"Park","year":"2003","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib132","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvh.12134","article-title":"Combinations of eight key mutations in the X\/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma","volume":"21","author":"Park","year":"2014","journal-title":"J. Viral Hepat."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib133","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib134","article-title":"The paradox of HBV evolution as revealed from a 16th century mummy","volume":"14","author":"Patterson","year":"2018","journal-title":"PLoS Pathog."},{"issue":"13","key":"10.1016\/j.virol.2024.110197_bib135","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/QAD.0000000000003689","article-title":"A genetic variation in fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation","volume":"37","author":"van Pul","year":"2023","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib136","first-page":"E28","article-title":"Association between HBx variations and development of severe liver disease among Indonesian patients","volume":"65","author":"Putri","year":"2019","journal-title":"Kobe J. Med. Sci."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib137","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jhep.2023.12.032","article-title":"Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels","volume":"80","author":"Qi","year":"2024","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2012.12.007","article-title":"The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir","volume":"97","author":"Qin","year":"2013","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098257","article-title":"Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China","volume":"9","author":"Qu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2003.11.025","article-title":"Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases","volume":"40","author":"Raimondo","year":"2004","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib141","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2008.05.005","article-title":"End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions","volume":"151","author":"Ramachandran","year":"2008","journal-title":"J. Virol. Methods"},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025232","article-title":"Evaluation of intra-host variants of the entire hepatitis B virus genome","volume":"6","author":"Ramachandran","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.virol.2024.110197_bib143","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2893.2009.01254.x","article-title":"Hepatitis B virus genotype and basal core promoter\/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis","volume":"17","author":"Ren","year":"2010","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib144","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.antiviral.2010.09.012","article-title":"Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery","volume":"88","author":"Rhee","year":"2010","journal-title":"Antivir. Res."},{"issue":"44","key":"10.1016\/j.virol.2024.110197_bib145","doi-asserted-by":"crossref","first-page":"15821","DOI":"10.1073\/pnas.0504874102","article-title":"A structural model for maturation of the hepatitis B virus core","volume":"102","author":"Roseman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.virol.2024.110197_bib146","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01082-18","article-title":"Assembly properties of hepatitis B virus core protein mutants correlate with their resistance to assembly-directed antivirals","volume":"92","author":"Ruan","year":"2018","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2024.110197_bib147","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jmv.23260","article-title":"Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: a case-control study in Thailand","volume":"84","author":"Sa-Nguanmoo","year":"2012","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib148","first-page":"400","article-title":"Virological factors associated with the occurrence of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection analyzed through ultradeep sequencing","volume":"221","author":"Sakamoto","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2024.110197_bib149","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmi.2018.11.017","article-title":"The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro","volume":"25","author":"Salpini","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.canlet.2015.12.008","article-title":"A novel mutant 10Ala\/Arg together with mutant 144Ser\/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines","volume":"371","author":"Shi","year":"2016","journal-title":"Cancer Lett."},{"issue":"33","key":"10.1016\/j.virol.2024.110197_bib151","doi-asserted-by":"crossref","first-page":"25858","DOI":"10.1074\/jbc.M003578200","article-title":"Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway","volume":"275","author":"Shih","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2024.110197_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.633341","article-title":"An in vitro study on the role of hepatitis B virus X protein C-terminal truncation in liver disease development","volume":"12","author":"Siddiqui","year":"2021","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib153","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/JVI.02011-08","article-title":"Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen","volume":"83","author":"Solmone","year":"2009","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/v14091887","article-title":"HBx 128-133 deletion affecting HBV mother-to-child transmission weakens HBV replication via reducing HBx level and CP\/ENII transcriptional activity","volume":"14","author":"Song","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3851\/IMP1887","article-title":"Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha2b: relation to response and HBV genotype","volume":"17","author":"Sonneveld","year":"2012","journal-title":"Antivir. Ther."},{"issue":"37","key":"10.1016\/j.virol.2024.110197_bib156","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1073\/pnas.1807155115","article-title":"Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma","volume":"115","author":"Sonntag","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10049","key":"10.1016\/j.virol.2024.110197_bib157","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib158","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","article-title":"Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate","volume":"29","author":"Summers","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.virol.2024.110197_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105448","article-title":"Naturally occurring pre-S mutations promote occult HBV infection by affecting pre-S2\/S promoter activity","volume":"208","author":"Sun","year":"2022","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib160","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1038\/s41467-024-47358-6","article-title":"Origin and dispersal history of hepatitis B virus in eastern Eurasia","volume":"15","author":"Sun","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.virol.2024.110197_bib161","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib162","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2008.07.038","article-title":"The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes","volume":"50","author":"Svicher","year":"2009","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib163","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/viro.2001.1239","article-title":"Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants","volume":"292","author":"Tai","year":"2002","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib164","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/hep.22878","article-title":"Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time","volume":"49","author":"Tai","year":"2009","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.virol.2024.110197_bib165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00535-003-1387-1","article-title":"Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection","volume":"39","author":"Tanaka","year":"2004","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.virol.2024.110197_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105178","article-title":"Early dynamic changes of quasispecies in the reverse transcriptase region of hepatitis B virus in telbivudine treatment","volume":"195","author":"Tang","year":"2021","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib167","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jmv.27278","article-title":"Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations","volume":"94","author":"Tarafdar","year":"2022","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib168","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/0016-5085(87)90614-7","article-title":"Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults","volume":"92","author":"Tassopoulos","year":"1987","journal-title":"Gastroenterology"},{"issue":"20","key":"10.1016\/j.virol.2024.110197_bib169","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1128\/JVI.00462-09","article-title":"A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J","volume":"83","author":"Tatematsu","year":"2009","journal-title":"J. Virol."},{"issue":"3 Pt B","key":"10.1016\/j.virol.2024.110197_bib170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3851\/IMP2655","article-title":"The 'Red Queen' dilemma--running to stay in the same place: reflections on the evolutionary vector of HBV in humans","volume":"18","author":"Tedder","year":"2013","journal-title":"Antivir. Ther."},{"issue":"8","key":"10.1016\/j.virol.2024.110197_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/v12080796","article-title":"Next-generation sequencing-based quantitative detection of hepatitis B virus pre-S mutants in plasma predicts hepatocellular carcinoma recurrence","volume":"12","author":"Teng","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.virol.2024.110197_bib172","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib173","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41575-020-00361-w","article-title":"Viral hepatitis and pregnancy","volume":"18","author":"Terrault","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib174","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2014-306977","article-title":"Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers","volume":"64","author":"Tseng","year":"2015","journal-title":"Gut"},{"issue":"5665","key":"10.1016\/j.virol.2024.110197_bib175","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1092066","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G","volume":"303","author":"Turelli","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib176","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/HEP.0000000000000335","article-title":"HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice","volume":"78","author":"Uchida","year":"2023","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.virol.2024.110197_bib177","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1128\/jvi.65.7.3521-3529.1991","article-title":"Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles","volume":"65","author":"Ueda","year":"1991","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000928","article-title":"Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis","volume":"6","author":"Vartanian","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2024.110197_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1045498","article-title":"Immune escape pathways from the HBV core(18-27) CD8 T cell response are driven by individual HLA class I alleles","volume":"13","author":"Walker","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.virol.2024.110197_bib180","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1128\/JVI.02164-09","article-title":"Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases","volume":"84","author":"Wang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110197_bib181","article-title":"Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients","volume":"S0168-8278(17)32261-4.","author":"Wang","year":"2017","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib182","first-page":"315","article-title":"Relationship between maternal PBMC HBV cccDNA and HBV serological markers and its effect on HBV intrauterine transmission","volume":"32","author":"Wang","year":"2019","journal-title":"Biomed. Environ. Sci."},{"issue":"10","key":"10.1016\/j.virol.2024.110197_bib183","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1038\/s41375-020-0936-4","article-title":"Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection","volume":"34","author":"Wang","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib184","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11262-020-01787-9","article-title":"An antiviral drug-resistant mutant of hepatitis B virus with high replication capacity in association with a large in-frame deletion in the preS1 region of viral surface gene","volume":"56","author":"Wang","year":"2020","journal-title":"Virus Gene."},{"key":"10.1016\/j.virol.2024.110197_bib185","article-title":"The impact of HBV quasispecies features on immune status in HBsAg+\/HBsAb+ patients with HBV genotype C using next-generation sequencing","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib186","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2013.02.015","article-title":"Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention","volume":"59","author":"Wen","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2024.110197_bib187","article-title":"Clinical cure induced by pegylated interferon alpha-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study","volume":"13","author":"Wen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2024.110197_bib188","article-title":"Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment","volume":"150\u2013151","author":"Winckelmann","year":"2022","journal-title":"J. Clin. Virol."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib189","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/CIRCRESAHA.117.310910","article-title":"Advances in transcriptomics: investigating cardiovascular disease at unprecedented resolution","volume":"122","author":"Wirka","year":"2018","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib190","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gutjnl-2019-318278","article-title":"Quasispecies characteristic in \"a\" determinant region is a potential predictor for the risk of immunoprophylaxis failure of mother-to-child-transmission of sub-genotype C2 hepatitis B virus: a prospective nested case-control study","volume":"69","author":"Xiao","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib191","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00535-010-0315-4","article-title":"Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure","volume":"46","author":"Xu","year":"2011","journal-title":"J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.virol.2024.110197_bib192","article-title":"Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant","volume":"6","author":"Xue","year":"2017","journal-title":"Emerg. Microb. Infect."},{"issue":"14","key":"10.1016\/j.virol.2024.110197_bib193","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/JVI.03540-12","article-title":"Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide","volume":"87","author":"Yan","year":"2013","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib194","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10620-014-3492-9","article-title":"Hepatitis B virus core promoter A1762T\/G1764A (TA)\/T1753A\/T1768A mutations contribute to hepatocarcinogenesis by deregulating Skp2 and P53","volume":"60","author":"Yan","year":"2015","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.virol.2024.110197_bib195","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.22889","article-title":"Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis","volume":"49","author":"Yang","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.virol.2024.110197_bib196","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1128\/JCM.00068-15","article-title":"Characterization of full-length genomes of hepatitis B virus quasispecies in sera of patients at different phases of infection","volume":"53","author":"Yang","year":"2015","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib197","first-page":"497","article-title":"Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies","volume":"27","author":"Yang","year":"2015","journal-title":"Chin. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib198","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jinf.2017.04.012","article-title":"Quasispecies characteristics in mother-to-child transmission of hepatitis B virus by next-generation sequencing","volume":"75","author":"Yang","year":"2017","journal-title":"J. Infect."},{"issue":"11","key":"10.1016\/j.virol.2024.110197_bib199","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1128\/AAC.00239-06","article-title":"Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif","volume":"50","author":"Yatsuji","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2024.110197_bib200","series-title":"CheckMate 459: A Randomized, Multi-Center Phase III Study of Nivolumab (NIVO) vs Sorafenib (SOR) as First-Line (1L) Treatment in Patients (Pts) with Advanced Hepatocellular Carcinoma (aHCC)","author":"Yau","year":"2019"},{"issue":"11","key":"10.1016\/j.virol.2024.110197_bib201","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib202","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/infdis\/jiq096","article-title":"Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B","volume":"203","author":"Yeung","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.virol.2024.110197_bib203","first-page":"790","article-title":"Hepatitis B immunoprophylactic failure and characteristics of the hepatitis B virus gene in mother-infant pairs in parts of China","volume":"29","author":"Yin","year":"2016","journal-title":"Biomed. Environ. Sci."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12964-021-00714-1","article-title":"Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis","volume":"19","author":"You","year":"2021","journal-title":"Cell Commun. Signal."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcv.2007.03.005","article-title":"Hepatitis B virus (HBV) genotypes\/subgenotypes in China: mutations in core promoter and precore\/core and their clinical implications","volume":"39","author":"Yuan","year":"2007","journal-title":"J. Clin. Virol."},{"issue":"14","key":"10.1016\/j.virol.2024.110197_bib206","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1128\/JVI.00577-13","article-title":"The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication","volume":"87","author":"Zhang","year":"2013","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib207","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/jgh.13316","article-title":"Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma","volume":"31","author":"Zhang","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.virol.2024.110197_bib208","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00535-017-1334-1","article-title":"Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma","volume":"52","author":"Zhang","year":"2017","journal-title":"J. Gastroenterol."},{"issue":"17","key":"10.1016\/j.virol.2024.110197_bib209","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02120-17","article-title":"CD8(+) T-cell response-associated evolution of hepatitis B virus core protein and disease progress","volume":"92","author":"Zhang","year":"2018","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib210","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/s41598-019-44604-6","article-title":"Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib211","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/gutjnl-2018-317725","article-title":"A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice","volume":"69","author":"Zhang","year":"2020","journal-title":"Gut"},{"issue":"35","key":"10.1016\/j.virol.2024.110197_bib212","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41388-021-01942-y","article-title":"Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.virol.2024.110197_bib213","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/JHC.S348690","article-title":"Nonsynonymous C1653T mutation of hepatitis B virus X gene enhances malignancy of hepatocellular carcinoma cells","volume":"9","author":"Zhang","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"2","key":"10.1016\/j.virol.2024.110197_bib214","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12072-023-10631-9","article-title":"Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B","volume":"18","author":"Zhang","year":"2024","journal-title":"Hepatol Int."},{"issue":"1","key":"10.1016\/j.virol.2024.110197_bib215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2023.09.019","article-title":"Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers","volume":"80","author":"Zhang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2024.110197_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199317","article-title":"The dynamic variation position and predominant quasispecies of hepatitis B virus: novel predictors of early hepatocarcinoma","volume":"341","author":"Zhang","year":"2024","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.virol.2024.110197_bib217","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.virs.2023.06.004","article-title":"HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK\/MAPK pathway","volume":"38","author":"Zhao","year":"2023","journal-title":"Virol. Sin."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:25:39Z","timestamp":1759368339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224002186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":216,"alternative-id":["S0042682224002186"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110197","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution and diversity of the hepatitis B virus genome: Clinical implications","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110197"}}